Pfizer, Inc.

Equities

PFE

US7170811035

Pharmaceuticals

Market Closed - Nyse 04:00:34 2024-05-24 pm EDT 5-day change 1st Jan Change
28.88 USD +0.66% Intraday chart for Pfizer, Inc. +0.84% +0.31%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
US, European nations consider vaccinating workers exposed to bird flu RE
Novavax awaits FDA decision on whether its next COVID shot can be offered in US RE
Cogent Reports Positive Cancer Combo Treatment Trial Data; Names Commercial Chief MT
Global markets live: Anglo American, Nvidia, Apple, Amazon, Tesla, Walt Disney... Our Logo
Pfizer: initiative against antibiotic resistance in Malawi CF
The market is good to go until Nvidia’s next quarterly results Our Logo
News Highlights : Top Company News of the Day - Thursday at 9 AM ET DJ
BioMérieux, Pfizer to Collaborate on Antimicrobial Resistance Initiative in Malawi MT
Asymchem Laboratories Buys Pfizer's Former UK Site; Hong Kong Shares Slide 3% MT
News Highlights : Top Company News of the Day - Thursday at 3 AM ET DJ
News Highlights : Top Company News of the Day - Thursday at 1 AM ET DJ
News Highlights : Top Company News of the Day - Wednesday at 11 PM ET DJ
News Highlights : Top Company News of the Day - Wednesday at 9 PM ET DJ
Health Care Up as Vaccine Makers Gain - Health Care Roundup DJ
US IS IN 'ACTIVE CONVERSATIONS' WITH MRNA VACCINE MAKERS PFIZER… RE
Sector Update: Health Care Stocks Slightly Higher Late Afternoon MT
Sector Update: Health Care MT
Pfizer to Cut Costs in Multi-Year Effort -- Update DJ
Pfizer Looks for $1.5 Billion in Savings by 2027, Expects One-Time Cost Reduction Charge of $1.7 Billion MT
Pfizer to Cut Costs in Multi-Year Effort DJ
Pfizer targets $1.5 bln in savings by 2027 as it streamlines operations RE
Pfizer launches multi-year cost-cuts program, eyes $1.5 bln in savings RE
Pfizer: RSV vaccine launched in Canada CF
Sector Update: Health Care Stocks Advance Late Afternoon MT
China-Based Asymchem Laboratories Will Operate Former Pfizer Manufacturing Facility in UK DJ
Chart Pfizer, Inc.
More charts
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.88 USD
Average target price
31.92 USD
Spread / Average Target
+10.51%
Consensus
  1. Stock Market
  2. Equities
  3. PFE Stock
  4. News Pfizer, Inc.
  5. Pfizer's RSV Vaccine Meets Primary Endpoints in Study of Participants Under 60 Years; Seeks Expanded Access